Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
VRTX [NASD]
Vertex Pharmaceuticals Incorporated
Healthcare | Biotechnology | USA
statements
IndexS&P 500 P/E20.71 EPS (ttm)10.30 Insider Own0.20% Shs Outstand259.96M Perf Week0.15%
Market Cap54.66B Forward P/E16.29 EPS next Y13.10 Insider Trans-12.97% Shs Float259.37M Perf Month-0.44%
Income2.71B PEG1.13 EPS next Q2.72 Inst Own94.40% Short Float1.92% Perf Quarter-8.39%
Sales6.21B P/S8.81 EPS this Y128.00% Inst Trans-1.51% Short Ratio2.38 Perf Half Y-19.74%
Book/sh33.61 P/B6.35 EPS next Y15.63% ROA25.70% Target Price284.88 Perf Year-14.54%
Cash/sh25.99 P/C8.21 EPS next 5Y18.33% ROE35.20% 52W Range202.57 - 306.08 Perf YTD-9.73%
Dividend- P/FCF18.26 EPS past 5Y45.30% ROI26.40% 52W High-30.20% Beta0.67
Dividend %- Quick Ratio4.20 Sales past 5Y43.20% Gross Margin88.10% 52W Low5.47% ATR4.88
Employees3400 Current Ratio4.30 Sales Q/Q15.20% Oper. Margin46.00% RSI (14)48.69 Volatility2.17% 2.13%
OptionableYes Debt/Eq0.07 EPS Q/Q3.90% Profit Margin43.70% Rel Volume0.61 Prev Close213.35
ShortableYes LT Debt/Eq0.06 EarningsFeb 01 AMC Payout0.00% Avg Volume2.10M Price213.64
Recom1.80 SMA20-0.52% SMA50-0.47% SMA200-11.84% Volume547,434 Change0.14%
Feb-23-21Upgrade Robert W. Baird Neutral → Outperform $220 → $252
Feb-02-21Reiterated H.C. Wainwright Buy $315 → $275
Dec-30-20Initiated Daiwa Securities Outperform $250
Nov-30-20Upgrade RBC Capital Mkts Sector Perform → Outperform $247 → $267
Nov-20-20Initiated Bernstein Outperform $225
Oct-28-20Initiated UBS Buy $287
Jul-31-20Reiterated H.C. Wainwright Buy $295 → $315
Jul-08-20Downgrade Morgan Stanley Overweight → Equal-Weight $300
Apr-30-20Reiterated H.C. Wainwright Buy $270 → $295
Apr-28-20Downgrade RBC Capital Mkts Outperform → Sector Perform $250 → $260
Mar-04-20Initiated Barclays Overweight $271
Jan-31-20Downgrade Robert W. Baird Outperform → Neutral $210 → $230
Nov-19-19Upgrade Guggenheim Neutral → Buy $252
Nov-12-19Initiated SunTrust Buy $235
Oct-17-19Resumed BofA/Merrill Buy $220
Sep-03-19Upgrade Goldman Neutral → Buy $226 → $254
Aug-01-19Downgrade Needham Buy → Hold
May-23-19Resumed Citigroup Buy $205
May-21-19Initiated Credit Suisse Outperform $209
Apr-12-19Initiated Evercore ISI In-line
Apr-11-21 09:03AM  
3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks
Motley Fool
Apr-08-21 04:20PM  
Biotech Stocks Could Use A Win Will The First Quarter Offer That?
Investor's Business Daily
Apr-07-21 06:01AM  
3 Top Biotech Stocks to Buy in April
Motley Fool
Apr-05-21 05:51AM  
3 Value Stocks That'll Make You Richer in April (and Beyond)
Motley Fool
Apr-02-21 08:06AM  
Here's the Holy Grail of Gene Editing
Motley Fool
Mar-31-21 01:33PM  
Biotech Stock Roundup: BLUE/BMY's CAR T Therapy Nod, KLDO's COVID-19 Study News & More
Zacks
Mar-28-21 06:01AM  
3 Top Biotech Stocks to Buy Right Now
Motley Fool
Mar-26-21 07:23AM  
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat People With Cystic Fibrosis With At Least One F508del Mutation
Business Wire
Mar-24-21 07:21PM  
Vertex Receives Australian TGA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat People With Cystic Fibrosis Ages 12 Years and Older Who Have At Least One F508del Mutation
Business Wire
05:50PM  
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Markets: What You Should Know
Zacks
08:19AM  
The Zacks Analyst Blog Highlights: Abbott Laboratories, AstraZeneca, Booking, Vertex Pharmaceuticals and Yum China
Zacks
Mar-23-21 02:38PM  
Top Analyst Reports for Abbott, AstraZeneca & Booking Holdings
Zacks
10:12AM  
Is VRTX Stock A Buy or Sell?
Insider Monkey
Mar-22-21 06:04AM  
3 Stocks Cathie Wood Likes That Should Make You Rich
Motley Fool
Mar-20-21 06:30AM  
2 Top Growth Stocks That Could Make You Richer in March (And Beyond)
Motley Fool
06:04AM  
3 Top Healthcare Stocks to Buy Right Now
Motley Fool
Mar-17-21 11:48AM  
Here Are 5 Undervalued Biopharma Stocks
Barrons.com
Mar-16-21 12:19PM  
Heres Why Vertex (VRTX) Landed in Alger Spectras Detractor List
Insider Monkey
08:24AM  
Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Simply Wall St.
Mar-14-21 06:18AM  
3 Top Biotech Stocks to Buy in March
Motley Fool
05:51AM  
5 Disruptive Stocks to Buy for a Biden Bull Market
Motley Fool
Mar-11-21 05:45PM  
Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know
Zacks
08:52AM  
Vertex (VRTX) Type I Diabetes Candidate Clinical Study Begins
Zacks
Mar-10-21 01:04PM  
Vertex to begin Phase 1/2 trial of treatment for people with type 1 diabetes
MarketWatch
07:55AM  
Vertex Announces FDA Fast Track Designation and Initiation of a Phase 1/2 Clinical Trial for VX-880, a Novel Investigational Cell Therapy for the Treatment of Type 1 Diabetes
Business Wire
Mar-09-21 10:25AM  
Quant Genius Billionaire Jim Simons Top 10 Stock Picks
Insider Monkey
06:06AM  
5 Stocks to Watch Amid Continued Expansion in the Biotech Industry
Zacks
Mar-07-21 07:19AM  
Barron's Latest Picks And Pans: Lowe's, Microsoft, Vertex Pharmaceuticals, ViacomCBS And More
Benzinga
06:06AM  
Forget GameStop, AMC, and Sundial: These Are the Best Stocks to Buy Right Now
Motley Fool
Mar-05-21 07:00AM  
Vertex Stock Fell After a Setback on a New Drug. Its an Opportunity for Investors.
Barrons.com
Mar-03-21 11:30AM  
Vertex (VRTX) Down 2.4% Since Last Earnings Report: Can It Rebound?
Zacks
Mar-02-21 05:51AM  
3 Growth Stocks That'll Make You Richer in March (and Beyond)
Motley Fool
Feb-24-21 09:01AM  
Vertex to Present at the Cowen Health Care Conference on March 2
Business Wire
Feb-21-21 06:36AM  
Forget Bitcoin: 4 Stocks to Buy Hand Over Fist Instead
Motley Fool
Feb-20-21 07:10AM  
What Should Vertex Pharmaceuticals Buy With its $6.6 Billion Stash?
Motley Fool
Feb-19-21 07:50AM  
Here's Why Vertex Pharmaceuticals' Fourth Quarter Was Better Than It First Appeared
Motley Fool
Feb-18-21 12:49PM  
Is Vertex Pharmaceuticals (VRTX) Stock a Buy For 2021?
Insider Monkey
Feb-17-21 02:00PM  
Here's What Caused Royalty Pharma's Mixed Results in Q4
Motley Fool
08:19AM  
Wall Street Looks Again at Bluebird, Rivals, After Gene-Therapy Setback
Barrons.com
Feb-15-21 06:22AM  
3 Healthcare Stocks I'd Buy Right Now
Motley Fool
Feb-14-21 05:51AM  
5 Sizzling Growth Stocks to Buy for a Biden Bull Market
Motley Fool
Feb-11-21 08:53AM  
Should You Take Comfort From Insider Transactions At Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)?
Simply Wall St.
Feb-06-21 05:36PM  
Top 10 Large-Cap Healthcare Stocks to Buy Now
Insider Monkey
Feb-05-21 09:32AM  
CRISPR (CRSP) to Report Q4 Earnings: What's in the Cards?
Zacks
07:55AM  
3 Reasons It's Not Too Late to Buy Vertex Pharmaceuticals
Motley Fool
Feb-03-21 10:25AM  
Biotech Stock Roundup: AMGN, VRTX Q4 Results, SAVA's Encouraging Drug Data & More
Zacks
06:10AM  
Ignore GameStop: Here Are 3 Better Stocks
Motley Fool
Feb-02-21 04:35PM  
Why Vertex Pharmaceuticals Stock Fell Today
Motley Fool -6.23%
10:26AM  
Vertex CEO says company is seeking to make 'transformative' deals
MarketWatch
10:25AM  
Vertex (VRTX) Q4 Earnings Miss, Revenues Beat Estimates
Zacks
06:03AM  
Why Vertex Pharmaceuticals' Solid Q4 Results Weren't Good Enough
Motley Fool
Feb-01-21 10:30PM  
Vertex Pharmaceuticals Inc (VRTX) Q4 2020 Earnings Call Transcript
Motley Fool
05:56PM  
Markets Snap Back into Bullish Territory
Zacks
05:25PM  
Vertex Pharmaceuticals (VRTX) Lags Q4 Earnings Estimates
Zacks
04:53PM  
Vertex Stock Dips On Mixed Report; Investors Eye Its Next Catalysts
Investor's Business Daily
04:39PM  
Vertex Pharmaceuticals: Q4 Earnings Insights
Benzinga
04:01PM  
Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results
Business Wire
02:30PM  
Vertex Pharmaceuticals, Inc. to Host Earnings Call
ACCESSWIRE
06:06AM  
3 Top Stocks That'll Make You Richer in February (and Beyond)
Motley Fool
05:43AM  
Zacks.com featured highlights include: Crocs, AGCO, Meritage Homes and Vertex Pharmaceuticals
Zacks
Jan-31-21 03:58AM  
Earnings to Watch Next Week: Pfizer, Alibaba, Amazon, Alphabet and Qualcomm in Focus
FX Empire
Jan-30-21 01:19PM  
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More
Benzinga
Jan-29-21 10:12AM  
Earnings Preview for Vertex Pharmaceuticals
Benzinga
09:39AM  
Will Strong Veklury Sales Aid Gilead's (GILD) Q4 Earnings?
Zacks
09:31AM  
Vertex's (VRTX) IND for Type I Diabetes Drug Gets FDA Clearance
Zacks
08:44AM  
Why Earnings Season Could Be Great for Vertex (VRTX)
Zacks
08:22AM  
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
Zacks
07:45AM  
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
Benzinga
06:12AM  
3 Top Healthcare Stocks to Buy Right Now
Motley Fool
Jan-28-21 04:11PM  
Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes (T1D)
Business Wire
08:42AM  
Will Trikafta Drive Vertex's (VRTX) Revenues in Q4 Earnings?
Zacks
Jan-27-21 11:13AM  
Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Zacks -5.21%
11:05AM  
Biotech Stock Roundup: Coronavirus Updates From REGN, MRNA, & Other Updates
Zacks
Jan-26-21 09:40AM  
The Zacks Analyst Blog Highlights: NIKE, Amgen, Morgan Stanley, Vertex Pharma and Moderna
Zacks
08:30AM  
Vertex Announces U.S. FDA Acceptance of Supplemental New Drug Application for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations
Business Wire
Jan-25-21 05:45PM  
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Zacks
03:45PM  
Top Stock Reports for NIKE, Amgen & Morgan Stanley
Zacks
12:30PM  
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks
06:01AM  
Why I'm Betting Big on This 1 Megatrend
Motley Fool
Jan-24-21 07:10AM  
Where to Invest $1 Million Right Now
Motley Fool
Jan-22-21 09:01AM  
Vertex to Announce Fourth-Quarter 2020 Financial Results on February 1
Business Wire
05:51AM  
Got $4,000? 4 Game-Changing Stocks to Buy in 2021
Motley Fool
Jan-21-21 12:10PM  
Why the Earnings Surprise Streak Could Continue for Vertex (VRTX)
Zacks
Jan-20-21 08:23AM  
The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics
Zacks
Jan-19-21 10:46AM  
CRISPR (CRSP) Up More Than 80% in Past 3 Months: Here's Why
Zacks
Jan-18-21 08:03AM  
5 Stocks Expected to Crush the S&P 500
Investopedia
Jan-15-21 05:45PM  
Vertex Pharmaceuticals (VRTX) Stock Moves -0.25%: What You Should Know
Zacks
Jan-11-21 08:02AM  
The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticals
Zacks
Jan-10-21 07:05AM  
The Top 3 Biotech Stocks to Buy in 2021
Motley Fool
06:06AM  
3 Top Biotech Picks for 2021
Motley Fool
Jan-08-21 05:45PM  
Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know
Zacks
Jan-07-21 09:01AM  
Vertex to Present at the J.P. Morgan Healthcare Conference on January 11
Business Wire
07:00AM  
Where to Invest $100,000 Right Now
Motley Fool
Jan-06-21 06:25AM  
Expecting a $600 Stimulus Check? These 2 Stocks Should Rebound Big
Motley Fool
Jan-05-21 07:08AM  
3 Recession-Proof Healthcare Stocks to Buy for 2021
Motley Fool
06:36AM  
3 Nasdaq 100 Stocks That Can Make You a Boatload of Money in 2021
Motley Fool
06:00AM  
Get Ready for Health-Care Stocks to Go Wild. How to Play Them.
Barrons.com
Jan-04-21 09:30AM  
Axsome's (AXSM) Migraine Drug Shows Long-Term Safety in Study
Zacks
Jan-03-21 10:13PM  
Why The EPS Rating Is One Key To Picking The Best Stocks
Investor's Business Daily
Jan-01-21 06:36AM  
4 Unstoppable Stocks to Buy for a Biden Bull Market in 2021
Motley Fool
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 12 years of age or older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator, or CFTR, gene. Its pipeline includes Pipeline for Alpha-1 antitrypsin deficiency that is in Phase 2 clinical trial; VX-864, a second investigational small molecule corrector for the treatment of AAT deficiency, which is in Phase 1 clinical trial; and VX-147 that completed a Phase 1 clinical trial for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. Vertex Pharmaceuticals Incorporated has collaborations with CRISPR Therapeutics AG; Arbor Biotechnologies, Inc.; Moderna, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany; X-Chem, Inc.; Janssen Pharmaceuticals, Inc.; Merck KGaA; Kymera Therapeutics; Ribometrix, Inc.; Molecular Templates, Inc.; and Affinia Therapeutics. The company was founded in 1989 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanna BastianoEVP, Cell & Genetic TherapiesApr 05Sale214.141,686361,04635,834Apr 07 04:04 PM
Liu JoySVP, General CounselMar 05Sale209.695,1411,078,0188,253Mar 08 04:10 PM
Silva Paul MSVP & Chief Accounting OfficerMar 01Sale211.452,782588,2559,884Mar 02 04:07 PM
Silva Paul MSVP & Chief Accounting OfficerFeb 25Sale213.471,080230,55114,884Feb 26 04:23 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 25Sale213.423,586765,30740,133Feb 26 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 25Sale213.383,028646,12530,837Feb 26 04:18 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 25Sale213.543,634775,98941,103Feb 26 04:07 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 25Sale213.393,028646,13933,589Feb 26 04:03 PM
Silva Paul MSVP & Chief Accounting OfficerFeb 18Sale211.834,295909,82816,828Feb 19 04:21 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 18Sale211.839,2641,962,36646,665Feb 19 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 18Sale211.837,8251,657,55636,281Feb 19 04:18 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 18Sale211.827,8251,657,48147,635Feb 19 04:08 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 18Sale211.837,8251,657,59039,033Feb 19 04:05 PM
Sachdev AmitEVP, Chief Patient OfficerFeb 11Sale210.554,460939,06863,542Feb 16 04:20 PM
Silva Paul MSVP & Chief Accounting OfficerFeb 11Sale210.571,498315,43723,863Feb 16 04:24 PM
Sanna BastianoEVP, Cell & Genetic TherapiesFeb 11Sale210.561,686355,01238,864Feb 16 04:22 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 11Sale210.564,318909,17950,346Feb 16 04:15 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 11Sale210.555,1561,085,59361,700Feb 16 04:07 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 11Sale210.545,2831,112,27453,098Feb 16 04:02 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 05Option Exercise86.521,930166,98459,157Feb 09 07:44 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 05Sale215.001,930414,95057,227Feb 09 07:44 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 03Option Exercise86.521,554134,45271,511Feb 05 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 03Option Exercise86.5240034,60857,627Feb 05 04:52 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerFeb 03Sale213.741,554332,14669,957Feb 05 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffFeb 03Sale216.5640086,62457,227Feb 05 04:52 PM
Sachdev AmitEVP, Chief Patient OfficerNov 16Sale223.53429,38835,103Nov 18 04:16 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffNov 16Sale223.539120,34126,838Nov 18 04:12 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerNov 16Sale223.6471,56535,179Nov 18 04:11 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 16Sale223.47388,49228,902Nov 18 04:10 PM
SACHS BRUCE IDirectorNov 10Buy217.3615,0003,260,46526,210Nov 12 08:18 AM
Parini MichaelEVP, Chief Adm, Leg & BD OffNov 04Option Exercise86.522,330201,59229,168Nov 06 04:09 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffNov 04Sale217.742,330507,32926,838Nov 06 04:09 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerNov 03Option Exercise86.521,553134,36636,732Nov 05 04:16 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerNov 03Sale211.921,553329,11535,179Nov 05 04:16 PM
Bhatia Sangeeta N.DirectorOct 05Option Exercise126.688,7291,105,79014,424Oct 07 04:11 PM
Bhatia Sangeeta N.DirectorOct 05Sale266.7910,5162,805,5183,908Oct 07 04:11 PM
Silva Paul MSVP & ControllerAug 06Option Exercise169.391,078182,59816,010Aug 10 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 06Option Exercise155.571,223190,26230,125Aug 10 04:13 PM
Kewalramani ReshmaCEO & PresidentAug 06Option Exercise179.682,073372,48228,699Aug 10 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 06Option Exercise155.571,223190,26228,061Aug 10 04:22 PM
Silva Paul MSVP & ControllerAug 06Sale271.171,078292,31914,932Aug 10 04:24 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 06Sale271.191,223331,66328,902Aug 10 04:13 PM
Kewalramani ReshmaCEO & PresidentAug 06Sale271.202,073562,20526,626Aug 10 04:19 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 06Sale271.201,223331,67226,838Aug 10 04:22 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 03Option Exercise86.522,330201,59231,232Aug 05 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerAug 03Option Exercise86.521,553134,36636,732Aug 05 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 03Option Exercise86.522,330201,59229,168Aug 05 04:20 PM
Silva Paul MSVP & ControllerAug 03Option Exercise86.5280969,99515,741Aug 05 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerAug 03Option Exercise86.521,941167,93537,044Aug 05 04:51 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 03Sale278.242,330648,29028,902Aug 05 04:14 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerAug 03Sale278.391,553432,33735,179Aug 05 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffAug 03Sale278.282,330648,40226,838Aug 05 04:20 PM
Silva Paul MSVP & ControllerAug 03Sale278.30809225,14214,932Aug 05 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerAug 03Sale278.281,941540,13735,103Aug 05 04:51 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffJul 13Option Exercise90.292,125191,86628,963Jul 15 04:41 PM
Silva Paul MSVP & ControllerJul 13Option Exercise90.2986077,64915,792Jul 15 04:51 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffJul 13Sale292.052,125620,61026,838Jul 15 04:41 PM
Silva Paul MSVP & ControllerJul 13Sale292.03860251,14514,932Jul 15 04:51 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJul 10Sale293.15700205,20616,126Jul 14 04:16 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJul 07Option Exercise173.512,786483,40337,965Jul 09 04:13 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerJul 07Sale300.002,786835,80035,179Jul 09 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanJun 30Sale286.1532,7929,383,3042,261Jul 02 04:15 PM
Bhatia Sangeeta N.DirectorJun 02Sale282.88952269,2985,695Jun 03 04:22 PM
Kewalramani ReshmaCEO & PresidentMay 15Sale284.179928,13226,626May 19 04:35 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 15Sale284.0012034,08012,738May 19 04:33 PM
Silva Paul MSVP & ControllerMay 15Sale284.0015142,88514,932May 19 04:31 PM
Sachdev AmitEVP, Chief Patient OfficerMay 15Sale284.415816,49635,103May 19 04:29 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 15Sale284.406819,33926,838May 19 04:28 PM
Arbuckle Stuart AEVP, Chief Commercial OfficerMay 15Sale283.9811332,08935,179May 19 04:22 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 15Sale284.378223,31828,902May 19 04:21 PM
LEIDEN JEFFREY MExecutive ChairmanMay 12Option Exercise137.5288,53212,174,639129,353May 14 04:19 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 12Option Exercise187.531,304244,53930,206May 14 04:17 PM
LEIDEN JEFFREY MExecutive ChairmanMay 12Sale283.4794,37026,751,44034,983May 14 04:19 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 12Sale287.331,304374,67828,902May 14 04:17 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 11Option Exercise187.531,304244,53928,142May 13 04:18 PM
Sachdev AmitEVP, Chief Patient OfficerMay 11Option Exercise131.8910,6651,406,60745,768May 13 04:20 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 11Sale286.001,304372,94426,838May 13 04:18 PM
Sachdev AmitEVP, Chief Patient OfficerMay 11Sale282.6110,6653,014,01435,103May 13 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanMay 07Option Exercise137.5288,53412,174,982135,190May 08 04:20 PM
SACHS BRUCE IDirectorMay 07Option Exercise70.5545,0003,174,52556,210May 08 04:24 PM
SACHS BRUCE IDirectorMay 07Sale269.8045,00012,140,80611,210May 08 04:24 PM
LEIDEN JEFFREY MExecutive ChairmanMay 07Sale269.7894,36925,459,01340,821May 08 04:20 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 06Option Exercise155.571,222190,10730,124May 08 04:17 PM
Kewalramani ReshmaCEO & PresidentMay 06Option Exercise179.672,074372,63828,700May 08 04:19 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 06Option Exercise174.06966168,14613,704May 08 04:28 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 06Option Exercise155.571,222190,10728,060May 08 04:22 PM
Sachdev AmitEVP, Chief Patient OfficerMay 06Option Exercise131.8966988,23435,772May 08 04:23 PM
Silva Paul MSVP & ControllerMay 06Option Exercise169.381,076182,25516,008May 08 04:26 PM
Sachdev AmitEVP, Chief Patient OfficerMay 06Sale275.28669184,16235,103May 08 04:23 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 06Sale272.641,222333,16526,838May 08 04:22 PM
Silva Paul MSVP & ControllerMay 06Sale272.741,076293,47214,932May 08 04:26 PM
Tatsis OuraniaEVP, Chief Regulatory OfficerMay 06Sale272.70966263,43112,738May 08 04:28 PM
Kewalramani ReshmaCEO & PresidentMay 06Sale272.852,074565,88226,626May 08 04:19 PM
ALTSHULER DAVIDEVP, Global Research and CSOMay 06Sale272.661,222333,19528,902May 08 04:17 PM
Sachdev AmitEVP, Chief Patient OfficerMay 05Option Exercise131.8913,3561,761,52348,459May 06 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Option Exercise137.5288,53712,175,273141,028May 07 04:24 PM
LEIDEN JEFFREY MExecutive ChairmanMay 05Sale269.9494,37225,475,03746,656May 07 04:24 PM
Sachdev AmitEVP, Chief Patient OfficerMay 05Sale270.0113,3563,606,23235,103May 06 04:43 PM
Parini MichaelEVP, Chief Adm, Leg & BD OffMay 04Option Exercise86.522,330201,59229,168May 06 04:25 PM
Silva Paul MSVP & ControllerMay 04Option Exercise86.5280969,99515,741May 06 04:27 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.